Venous sinus thrombosis in a patient taking thalidomide [2]

Cerebrovascular Diseases

Volumn 18, Issue 2, 2004, Pages 175-177

  Lenz, Robert A ^a   Saver, Jeffrey ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 8; ESTROGEN; FOLIC ACID; GLIMEPIRIDE; HEPARIN; PAMIDRONIC ACID; PAROXETINE; PROGESTERONE; THALIDOMIDE; TOLTERODINE; WARFARIN;

AGED; CASE REPORT; CAUCASIAN; CEREBRAL SINUS THROMBOSIS; CONFUSION; FAMILY; FEMALE; HEADACHE; HOSPITAL ADMISSION; HUMAN; LABORATORY TEST; LETTER; MEDICAL EXAMINATION; MULTIPLE MYELOMA; NECK PAIN; PRIORITY JOURNAL;

AGED; ANGIOGENESIS INHIBITORS; FEMALE; HUMANS; MULTIPLE MYELOMA; SINUS THROMBOSIS, INTRACRANIAL; THALIDOMIDE;

EID: 4043178583     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079739     Document Type: Letter

References (10)

1. Barlogie B, Jagannath S, Desikan KR, et al: Total therapy with tandem transplants for newly diagnosed multiple myeloma. Blood 1999;93:55-65.
2. Bousser MG: Cerebral venous thrombosis: Diagnosis and management. J Neurol 2000;247:252-258.
3. Camba L, Peccatori J, Pescarollo A, et al: Thalidomide and thrombosis in patients with multiple myeloma. Haematologica 2001;86:1108-1109.
4. Escudier B, Lassau N, Leborgne S, et al: Thalidomide and venous thrombosis. Ann Intern Med 2002;136:711.
5. Flageul B, Wallach D, Cavelier-Balloy B, et al: Thalidomide et thromboses. Ann Dermatol Venereol 2000;128:148-149.
6. Kyrle PA, Minar E, Hirschl M, et al: High plasma levels of factor VIII and the risk of recurrent venous thromboembolism. N Engl J Med 2000;343:457-462.
7. Osman K, Comenzo R, Rajkumar SV: Deep venous thrombosis and thalidomide therapy for multiple myeloma. N Engl J Med 2001;344:1951-1952.
8. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP: Oral contraceptives, hormone replacement therapy and thrombosis. Thromb Haemost 2001;86:112-123.
9. Singhal S, Mehta J, Desikan R, et al: Antitumour activity of thalidomide in refractory multiple myeloma. N Engl J Med 1999;341:1565-1571.
10. Zangari M, Anaissie E, Barlogie B, et al: Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood 2001;98:1614-1615.